SIN-1, a nitric oxide synthase donor, reduces isoproterenol-stimulated calcium current in both wild type and genetically engineered mouse hearts: findings from G protein subunit gene knockout mice  by Chen, Fuhua et al.
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829-5 Response  to Pharmacologic Agents of  D lseoc iated  
Pulmonary Vein Firing InlUeting Atr ia l  F ibr i l la t ion 
Nassir F. Marrooche. Chdstopher Cole, Thomas Drasing, Ahmed AbduI-Karim, Dianna 
Bash, David Martin, Patrick Tchou, Andrea Natale, Cleveland Clinic, Cleveland, Ohio, 
Pulmonary veins firing (PVF) have been shown to initiate and maintain atrial fibrillation 
(AF). The elctrophysiologic behavior of PVF and the mechanism responsible for initiating 
AF by these tdggers is still to be defined. We report the respone of isolated PVF to ade- 
nosine (AD), isoproterenol (ISO), verapamil (VR) and phenylephrine (PE) trying to under- 
stand the physiology of AF initiation by PVs tdggers, 
Methods and Results: One hundred and eighty-two patients (141 men; mean age 
53+11 years) presented for focal mapping and ablation of symptomatic AF. After isola- 
tion, stable dissociated fidng was documented in 10% (60/601) of the treated PVs. AD 
(18 mg IV bolus), ISO (infusion rate of 15 mcg/hour), VR (10 mg IV bolus) and PE (200 
mcg bolus followed by infusion at 100 mcg/hour) were administered in these patients, 
respectively. The CL behavior of PVF before and after administration of drugs is listed in 
table 1. 
Baseline During AD Immediately Post ISO Post VR Post PE 
Post AD 
Atrial CL 720-J:40 ms 1800~:150 ms* 800~50ms 405+30 ms* 690+-30 ms 750-+40 ms* 
PVF CL 2175_+ 250ms supressed 2020+100 ms 675+95 ms* 1920"Z300 ms 2400"z240ms 
*P<0.05 compared to baseline 
Conclusion: Adenosine suppressed and isoproterenol appeared to increase the rate of 
the dissociated PV firing. Response to verspamil and phenylephrine were similar to the 
one exerts on the sinus node. Our preliminary data suggest that tissue responsible for fir- 
ing within the PV exhibits a response to pharmacologic agents similar to the sinus node 
cells. 
3:15 p.m. 
829-6 Efficacy of Nonsteroidal Antiinflammatory Medications 
for Prevention of Atr ia l  F ibr i l la t ion Following Coronary 
Artery Bypass Surgery 
Kiran K. Cheruku, Abdul Ghani, Faheem Ahmed, Pat Pappas, Paul Silverman, Allan 
Zellinger, Marc A. Silver, Advocate Chdst Medical Center, Oak Lawn, Illinois. 
Background: One of the most common complications of coronary artery bypass graft 
surgery (CABG) is atrial fibrillation (AF) and atrial flutter, occurring in 20-40% of 
patients(pts). It is associated with hemodynamic ompromise, stroke and prolonged hos- 
pitalization. The underlying pathogenesis remains elusive, but is considered to be multi- 
factorial, pericardial inflammation being one of them. 
Methods: We designed an open labeled prospective, randomized study consisting of pts 
undergoing first time CABG, Pts with prior history of AF, serum creatinine above 2.grog/ 
dl, pts on antiarrythmic treatment and pts undergoing valvular surgery were excluded. 
Group I received ketorolac intravenously for the first 24 hours after surgery or until able to 
take oral medications, at which point ibuprofen 500 mg orally three times a day was 
started. The dosage of ibuprofen was decreased to 400 mg three times daily if pts 
develop significant gastrointestinal symptoms. Group II received standard pain medica- 
tions other than non steroidal anti-inflammatory medications (NSAIDS) during their hos- 
pital stay. 
Results: We present preliminary data from the first 90 pts enrolled. Average age of pts 
was 64.4 yrs , there were 58 males (65%) and 32 females (35%). Group I had 47 
pts(52%) ,of which 32 were male. Hypertension was present in 54 pts (60%), 33 in group 
I and 21 in group II. There were 22 pts (24%) with diabetes, 13 in group I and 9 in group 
II. 42 pts (47%) had left ventricular dysfunction of which 22 were in group I and 20 in 
group II. A total of 13 pts (15%), developed AF, Only 2 (4.25%) in group I developed AF 
as compared to 11 (25.5%) in group II, with a p-value< 0.01 by Chi-square test. In two 
patients the dose of ibuprofen was decreased due to gastrointestinal symptoms,There 
were no other significant complications. 
Conclusions: The preliminary data presented shows a lower incidence of in-hospital 
post-CABG AF with the use of NSAIDS.This study supports the use of NSAIDS in all suit- 
able patients going for first time CABG, as they are an inexpensive and safe approach to 
prevent post -CABG AF. 
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1136-111 S IN- l ,  a Nitr ic  Ox ide  Synthsse Donor, Reduces 
I soprotereno l -S t imu le ted  Ca lc ium Cur rent  in Both  Wi ld  
Type and Genetically Engineered Mouse Heads: 
Findings From G Protein Subunlt Gene Knockout Mice 
Fuhua Chen, Meisheng Jiang, Wei Sun, Lutz Birnbaumer, Glenn T. Wetzel, UCLA School 
of Medicine, Los Angeles, California. 
Background: We have previously found that both the inhibitory (G-i) and the other type 
(G-o) proteins may play an important role in the muscednic regulation of L-type Ca2+ 
current (ICe-L) in cardiac ventdcular myocytes. However, the role of nitric oxide (NO) 
synthase as a mediator of these G protein coupled pathways remains controversial. The 
purpose of the present study was to determine whether 3-morpholinosydnonimine (SIN- 
1 ), a specific NO donor, could reduce isoproterenol (ISO)-stimulated increase in ICa-L in 
both wild type and G protein subunit gene knockout mouse ventricuiar cells. 
Methods: Single isolated ventricular myocyte were obtained from both wild-type (WT) 
and alpha subunit of G-o (G-o-alpha) protein knockout (G-o-alpha -/-) mice, Whole cell 
voltage clamp techniques were used to study the effect of SIN-1 on ISO-simulated ICa-L 
in ventricutar myocytes. 
Results: We found that perfusion of 10 microM ISO for 3-5 rain increased ICa-L current 
density by 57.9 percent (from 6.3±1.2 to 10.0~1.4 pNpF,  n=13, p<0.Ol) in G-o-alpha 
protein gene knockout mice, similar to our previous finding in wild type mouse cardiac 
cells. This indicates that the stimulatory G protein signal pathway is intact in these G-o- 
alpha protein gene knockout mice. SIN-1 (0.1 mM) significantly inhibited ISO-stimulatad 
ICa-L in G-o-alpha protein gene knockout mouse myocytes (by 35.5 percent, from 
10.0¢1.4 to 7.0±1.5 pNpF, n=13, p<0.0t ), as well as in wild type ventricular myocytes (by 
43.3 percent, from 11.4±1.5 to 6.5:L~.8 pNpF, n=5, p<0.05). The inhibitory effects of SIN- 
1 were reversible. Washout of SIN-1 generated almost full recovery of Ca2+ current 
amplitudes in G-o-alpha protein gene knockout mice (to 10.0±1.9 pNpF, n=7, p<0.Ol) 
and in wild type mice (to 10.1_+1.1 pNpF, n=5, p<0.05). 
Conclusion: These results demonstrate that NO donor produced significant inhibition of 
the ICa-L in mouse ventdcular myocytes. In addition, the presence of G-o protein was not 
required for this inhibitory effect, suggesting that SIN-1 provokes the inhibition of Ca2+ 
current downstream of G-o-alpha protein signal pathway. 
1136-112 Defect ive Regu la t ion  o f  L-Type Calcium Currents by 
Src -K inase  in Atr ia l  Card lomyocytes  F rom Pat ients  With 
Chronic Atr ia l  F ibr i l la t ion 
Maura Graiser. Christian R. Halaszovich, Marius Skasa, Christoph Stellbrink, Peter 
Hanrath, Andreas Luckhoff, Medical Clinic I, University Hospital RWTH-Aachen, Aachen, 
Germany, Department of Physiology, University Hospital RWTH-Aachen, Aachen, 
Germany. 
Background: Cardiac L-Type Ca(2+)currant (ICa,L) is inhibited by regulatory pathways 
involving protein tyrosine kinases (PTK). In atrial cardiomyocytes from patients with 
chronic atrial fibrillation (AF), ICa,L is characteristically depressed. Therefore, we studied 
whether PTK-mediated regulation of ICa,L is altered in chronic AI£ 
Methods: Single myocytes were isolated from right atrial appendages of patients under- 
going open heart surgery. 11 patients with AF were compared with 20 patients without 
atrial dysfunction (control). ICa,L was measured with the whole cell patch-clamp tech- 
nique. Genistain, a nonselective PTK-inhibitor, and PP1, a PTK-inhibitor selective for src- 
kinase, were used to evaluate receptor-associated as well as src-dependent regulation of 
ICa,L. 
Results: Genistein and PP1 both led to significant increases in ICa,L in cardiomyocytes 
from control patients. In AF cardiomyocytes basal ICa,L was depressed and was not 
enhanced by PPt. Genistein as well as isoproterenol, however, evoked increases in 
ICa,L that were (on a percent basis) not different in AF from control. 
Conclusions: ICa,L in chronic AF is not only decreased but has furthermore lost its regu- 
lation by src-kinase dependent signaling cascades, whereas other regulatory pathways 
remain intact. This selective regulatory dysfunction may be relevant in the process of 
atrial remodelling in chronic AF and may contribute to the electrical instability of the atdal 
myocardium. 
1136-113 Card iac  Hypertrophy and Electr ical  Remode l ing  
Develop Aeynchronously in the Chron ic  AV-B lock  Dog, 
Independently of AT1 Blockade 
Marieke Schoenmakers. Jet D. Leunissen, Jurren M. van Opstal, Hein J. Wellens, Marc 
A. Vos, Cardiology, Cardiovascular Research Institute Maastricht, Maastricht, The 
Netherlands. 
Background: Left ventricular hypertrophy and electrical remodeling Are considered to 
Be coupled, The renin-angiotansin system has been implicated in the development of 
hypertrophy. At 5 weeks the chronic AV-block dog has: 1) ventricular hypertrophy associ- 
ated With a transient increase in systemic angiotensinll and 2) enhanced susceptibility to 
Torsade de Pointes-arrhythmias due to lengthening of repolarization. To investigate par- 
alia1 development of these processes, time dependency was assessed in 5 groups in 
absence or presence of the ATt blocker Irbesartan (I). 
Methods: Endocardial MAP duration (D) of LV and RV was measured and susceptibility 
to Torsade de Pointes was tested by infusing Dcfetilide (0.025 mg/kg/5'). Hypertrophy 
